LD-2 disclosure · Registration
KARYOPHARM THERAPEUTICS
Coverage · Registration filing — establishes the registrant/client relationship. No periodic income or expenses are reported at registration.
Client
- Description
- Pharmaceutical manufacturer
- Location
- Massachusetts · United States of America
Registrant
- Description
- law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Rare disease policy, drug approval process
Lobbyistsms PATRICIA LOUISE DELOATCHE · ABIGAIL CARROLL
Covered position (ms PATRICIA LOUISE DELOATCHE): Health Policy Director, Sen. Orrin Hatch; Chief of Staff,Legislative Director, Legislative Assistant, Rep. MikeBilirakis
Covered position (ABIGAIL CARROLL): Detailee to the Energy and Commerce Committee, U.S. House of Representatives